Kezar Life Sciences, Inc. (KZR) Misses Q1 EPS by 2c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance